View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug...

AMAG Pharmaceuticals Files Submission in Response To the Food And Drug Administration’s Notice of Opportunity for a Hearing and Proposal To Withdraw Approval of Makena® (hydroxyprogesterone caproate injection) WALTHAM, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. has submitted its to the FDA’s Notice of Opportunity for a Hearing (“NOOH”) regarding the Agency’s proposal to withdraw approval for Makena—also referred to as 17-OHPC—the only FDA-approved treatment, along with five generic versions, to reduce preterm birth in women with a singleton pregnancy who have a h...

 PRESS RELEASE

AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprog...

AMAG Pharmaceuticals Requests Hearing to Maintain Makena® (Hydroxyprogesterone Caproate Injection) as a Treatment Option for Clinically Indicated Pregnant Patients WALTHAM, Mass., Oct. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) announced today that it has formally requested a public hearing in response to the U.S. Food and Drug Administration’s (FDA) proposal to withdraw its approval of Makena®, the only FDA-approved treatment, along with its equivalent generics, to reduce preterm birth. Makena was approved in 2011, based on the landmark NICHD MFMU trial by . A...

 PRESS RELEASE

AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Maken...

AMAG Pharmaceuticals Provides Update on FDA’s Proposal Regarding Makena® (Hydroxyprogesterone Caproate Injection)

 PRESS RELEASE

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals

Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals

 PRESS RELEASE

AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Glo...

AMAG Pharmaceuticals to Participate in H.C. Wainwright 22nd Annual Global Investment Conference WALTHAM, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Scott Myers, Chief Executive Officer, and Brian Piekos, Chief Financial Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual Global Investment Conference on Tuesday, September 15, 2020 at 10:30 a.m. Eastern Time. A live audio webcast of the virtual event will be accessible through the Investors section of the company’s website at . A replay of the webcast...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

 PRESS RELEASE

AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results a...

AMAG Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Corporate Update Financial guidance reissued to include EBITDA-positive projection for second-half 2020 Strategic shift and momentum build through recent business development activities Brian Piekos promoted to Chief Financial Officer Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the second quarter ended June 30, 2020. The company reported total revenu...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

 PRESS RELEASE

AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results ...

AMAG Pharmaceuticals to Host Second Quarter FY 2020 Financial Results Conference Call and Webcast on Thursday, August 6, 2020 WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its second quarter 2020 financial results will be released on Thursday, August 6, 2020 before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments. Dial-in NumberU.S./Canada Dial-in Number: (877) 412-6083International Dial-in N...

 PRESS RELEASE

AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets

AMAG Pharmaceuticals Completes Divestment of Women’s Health Assets Vyleesi® returned to Palatin Technologies Company focuses on optimizing marketed assets and development of its innovative pipeline WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) --  AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced AMAG and Palatin Technologies, Inc. have mutually terminated the January 2017 license agreement pursuant to which AMAG was granted exclusive rights to develop and commercialize Vyleesi® (bremelanotide), a melanocortin receptor agonist indicated for the treatment of acquired, general...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

IBTX INDEPENDENT BANK GROUP INC.
AXL AMERICAN AXLE & MANUFACTURING HLDGS
WHR WHIRLPOOL CORPORATION
PHM PULTEGROUP INC.
LII LENNOX INTERNATIONAL INC.
HZO MARINEMAX INC.
TUP TUPPERWARE BRANDS CORPORATION
AMN AMN HEALTHCARE SERVICES INC.
MIK MICHAELS COMPANIES INC
CARR CARRS GROUP
STC STEWART INFORMATION SERVICES CORPORATION
SRDX SURMODICS INC.
SBNY SIGNATURE BANK
RUN SUNRUN INC.
RLI RLI CORP.
RF REGIONS FINANCIAL CORPORATION
PRLB PROTO LABS INC.
PLXS PLEXUS CORP.
OFP OFG BANCORP
NWL NEWELL BRANDS INC
NTGR NETGEAR INC.
LNTH LANTHEUS HOLDINGS INC
LAD LITHIA MOTORS INC. CLASS A
IPG INTERPUBLIC GROUP OF COMPANIES INC.
HSY HERSHEY COMPANY
HSC HARSCO CORPORATION
HCA HCA HEALTHCARE INC
HAL HALLIBURTON COMPANY
GGG GRACO INC.
FL FOOT LOCKER INC.
FHN FIRST HORIZON CORPORATION
EQT EQT CORPORATION
ECHO ECHO GLOBAL LOGISTICS INC
CTAS CINTAS CORPORATION
CRMT AMERICA'S CAR-MART INC.
COLB COLUMBIA BANKING SYSTEM INC.
COG CABOT OIL & GAS CORPORATION
CNO CNO FINANCIAL GROUP INC.
CINF CINCINNATI FINANCIAL CORPORATION
CASH META FINANCIAL GROUP INC.
AN AUTONATION INC.
ADM ARCHER-DANIELS-MIDLAND COMPANY
LPG DORIAN LPG
CLB CORE LABORATORIES NV
SCL.TO SHAWCOR LTD.
ADTN ADTRAN INC.
CENT CENTRAL GARDEN & PET COMPANY
ELY CALLAWAY GOLF COMPANY
FSLR FIRST SOLAR INC.
MAT MATTEL INC.
VMI VALMONT INDUSTRIES INC.
WSO WATSCO INC.
ZUMZ ZUMIEZ INC.
TWTR TWITTER INC.
UAA UNDER ARMOUR INC. CLASS A
ICHR ICHOR HOLDINGS LTD.
CNX CNX RESOURCES CORPORATION
AMU AMAG PHARMACEUTICALS INC.
AROC ARCHROCK INC.
GTXMQ GARRETT MOTION INC.
GL GLOBE LIFE INC.
UFPI UFP INDUSTRIES
INC.
 PRESS RELEASE

AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing A...

AMAG Pharmaceuticals and Norgine B.V. Enter Into Exclusive Licensing Agreement to Commercialize Ciraparantag in Europe, Australia and New Zealand Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties   Collaboration further advances the development of ciraparantag WALTHAM, Mass. and AMSTERDAM, The Netherlands, July 23, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Norgine B.V., a leading European specialist pharmaceutical c...

Thanks to a better fundamental star rating, AMAG PHARMACEUTICALS sees ...

The independent financial analyst theScreener just awarded an improved star rating to AMAG PHARMACEUTICALS (US), active in the Pharmaceuticals industry. As regards its fundamental valuation, the title receives an improved star rating and now shows 4 out of 4 possible stars. With regard to its market behaviour, it remains unchanged and can be qualified as risky. theScreener considers that these elements allow slightly upgrading its rating to Neutral. As of the analysis date July 17, 2020, the clo...

 PRESS RELEASE

AMAG Announces Presentation of Ciraparantag Data at the International ...

AMAG Announces Presentation of Ciraparantag Data at the International Society on Thrombosis and Haemostasis Data from two Phase 2 randomized, placebo-controlled, dose-ranging studies using ciraparantag demonstrate efficacy and safety in the reversal of apixaban and rivaroxaban WALTHAM, Mass., July 12, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced the poster presentation of data from two Phase 2 randomized, placebo-controlled, dose ranging studies which showed safety and efficacy of ciraparantag reversing the effects of apixaban and rivaroxaban in he...

 PRESS RELEASE

AMAG Pharmaceuticals Announces Leadership Changes

AMAG Pharmaceuticals Announces Leadership Changes Company initiates CFO & COO succession plan; appoints internal seasoned finance leader as interim CFO Anthony Casciano assumes expanded role as AMAG’s COO WALTHAM, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Edward (Ted) Myles, Chief Financial and Chief Operating Officer, is leaving the Company. Brian Piekos, Senior Vice President of Finance, has been appointed interim Chief Financial Officer and will become a member of the company’s Executive Leadership Team. A...

 PRESS RELEASE

AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Health...

AMAG Pharmaceuticals to Participate in Jefferies Virtual Global Healthcare Conference WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate at the Jefferies Virtual Global Healthcare Conference on Wednesday, June 3, 2020 at 4:00 p.m. Eastern Time. A live audio webcast of the virtual event will be accessible through the Investors section of the company’s website at . A replay of the webcast will be archived on the company’s website for 30 days. About AMAGAMAG is a pharmaceutical company focused on bring...

 PRESS RELEASE

AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Mi...

AMAG Pharmaceuticals Completes Sale of its Rights to Intrarosa® to Millicent Pharma for up to $125 Million Transaction allows AMAG to advance its strategic focus on Feraheme, Makena and its pipeline, consistent with previously announced plans Millicent Pharma uniquely positioned to drive revenue growth of Intrarosa WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma Limited, a global pharmaceutical company formed by the Millicent Pharma management...

 PRESS RELEASE

AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results an...

AMAG Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update Feraheme® (ferumoxytol injection) posts strong first quarter results Company implements a workforce reduction of approximately 30 percent or 140 positions, as part of a planned decrease in operating expenses Conference call scheduled for 8:00 a.m. ET today WALTHAM, Mass., May 11, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the first quarter ended March 31, 2020. The company reported total revenues for the fi...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch